CTOs on the Move

LMA North America

www.lmana.com

 
LMA North America is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.lmana.com
  • 4660 La Jolla Village Dr Ste 900
    San Diego, CA USA 92122
  • Phone: 858.587.3500

Executives

Name Title Contact Details

Similar Companies

Thompson Health

Thompson Health is committed to providing quality health care to our community. Part of that commitment, includes providing information which will enable you to make informed health care decisions.

Massage Envy

Massage Envy Franchising LLC is an American massage and skin care national franchisor, based in Scottsdale, Arizona.

Healthcare Waste Solutions

Healthcare Waste Solutions is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kemin Industries

A nutritional ingredient manufacturer, Kemin is a privately held corporation, founded in 1961 by R.W. and Mary Nelson.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.